激光治疗中心性浆液性脉络膜视网膜病变的新进展

中心性浆液性脉络膜视网膜病变（ｃｅｎｔｒａｌｓｅｒｏｕｓｃｈｏｒｉｏｒｅｔｉｎｏｐａｔｈｙ，ＣＳＣ）是一种以后极部视网膜色素上皮功能障碍引起黄斑部视网膜色素上皮层局限性浆液性脱离的黄斑病变，为自限性疾病。多数患者急性发病后４～６个月自行好转，视力多可恢复正常，但也有部分患者病程迁延６个月以上，对视力损害明显。随着对该病病理生理认识的深入，多种治疗方案被应用于临床，但激光治疗被认为是目前治疗ＣＳＣ的主要疗法。激光疗法可以有效降低复发率，并对恢复视力有明显帮助，缩短病程，避免病变迁延不愈造成视力永久性损害。本文就临床使用激光疗法治疗ＣＳＣ的最新进展作一综述。

Recent advances in laser for central serous chorioretinopathy

Central serous chorioretinopathy ( CSC ) is a self-limiting posterior segment disease characterized by localized serous detachments of the retina neurepithelium layer of macular region which caused by retinal pigment epithelium ( RPE) dysfunction. Most acute episodes of CSC have a complete spontaneous resolution and improvement of vision which can restore to normal within 4 - 6 months. However , some patients may experience severe visual impairment due to the chronic and persistent course of disease after 6 months or more. With the continuous realization of its pathophysiologic process , more and more therapy strategies are applied, but laser therapies are considered to be the primary therapies for CSC , which can effectively reduce the recurrence rate.restore vision sigruficantly and shorten the duration , avoid the permanent visual damage. So , the latest developments of laser therapies in CSC are reviewed in this article.